Black Rose IndusQ2 FY24

Black Rose Indus Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹106.74P/E: 15.7Market Cap: ₹544 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Volumes increased substantially by more than 30% in Q2 FY24, though top-line growth was modest due to lower chemical prices.
  • Expect stronger sales volumes and good margins in chemical distribution driven by support from principals and penetration into new markets.
  • Export volumes in merchant export subdued due to US oil and gas sector recession, but expected to improve next financial year.
  • Key products like ethanolamine, purified isophthalic acid, and acrylonitrile expected to improve in volume and revenues in upcoming quarters.
  • Polyacrylamide liquid demand is expected to be robust, especially with increased ceramic tile exports, supporting higher sales volumes and improved margins.
  • Newer product developments (e.g., polycarboxylate dispersant, N-methylol acrylamide) anticipated to drive future revenue growth.
  • Manufacturing revenue has potential to grow close to distribution revenues, moving towards a 50:50 mix as manufacturing scales up.
  • Overall, focus on volume growth, export expansion, and new product launches underpin positive outlook.

See what Black Rose Indus management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no explicit mention of any current or immediate new fundraising through debt or equity in the transcript.
  • The company is currently debt-free with no long-term debt, as highlighted in the balance sheet discussion.
  • They have substantial internal accruals available for funding future projects and working capital needs.
  • Future capacity expansions and upcoming projects will likely be funded through internal accruals.
  • No announcements or plans regarding raising funds through debt or equity were made during the Q&A or presentation.

See what Black Rose Indus management said on order book — free account, 30 seconds.

Capex plans

Yes
- R&D building expected to be in place by next year (FY25). - Specialty chemical project in advanced stages; target for launch by FY25 at existing Jhagadia plant in collaboration with a Japanese principal. - Discussions with US and European companies for toll manufacturing projects related to Acrylamide chemistries. - Potential to expand Acrylamide liquid capacity by 60,000 MT at existing Jhagadia site when utilization consistently exceeds threshold. - Capex for new capacity additions expected to be low but subject to statutory approvals. - Continued focus on development and commercial launch of Polyacrylamide solids by Q3 of FY25. - Overall, strong internal accruals available for funding future projects and working capital needs; company remains zero long-term debt. These investments indicate ongoing strategic expansion and product development initiatives focused on specialty chemicals, capacity augmentation, and R&D infrastructure.

Track Black Rose Indus — get its next earnings analysis in your feed

How does Black Rose Indus rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisBlack Rose Indus
Rev 3Mar 3

How does Black Rose Indus rank in Chemicals & Petrochemicals?

Compare Black Rose Indus against every Chemicals & Petrochemicals company (Q2 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →